Ulcerative Colitis

...Shire plc: ADDERALL XR(R) - The Court Sets October 30, 2006 Bench Trial: Financial News - Yahoo!

Finance Yahoo!

My Yahoo!

Mail Welcome, Guest [Sign Out, My Account] Finance Home - Help HomeInvestingNews & CommentaryRetirement & PlanningBanking & CreditLoansTaxesSpecial EditionsColumnistsPersonal FinanceInvesting IdeasMarketsCompany FinancesProvidersGet QuotesSymbol LookupFinance Search Press ReleaseSource: Shire PLC Shire plc: ADDERALL XR(R) - The Court Sets October 30, 2006 Bench TrialFriday March 10, 6:00 pm ET PHILADELPHIA, Pennsylvania and BASINGSTOKE, England, March 10 /PRNewswire-FirstCall/ - Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that in the pending New York litigation between Shire and Barr Laboratories, Inc.

involving alleged infringement of U.S.

Patent Nos.

6,322,819 and 6,605,300, the Court in a pre-trial conference scheduled the bench trial to commence on October 30, 2006.

Notes to EditorsSHIRE PLCShire's strategic goal is to become the leading specialty pharmaceutical company that focuses on meeting the needs of the specialist physician.

Shire focuses its business on central nervous system, gastrointestinal, general products and human genetic therapies - all being areas in which Shire has a commercial presence.

The structure is sufficiently flexible to allow Shire to target new therapeutic areas to the extent opportunities arise through acquisitions.

Shire believes that a carefully selected portfolio of products with strategically ...

Read more...